Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 12/31/2013 | 12/31/2009 | 12/31/2005 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $1 | $0 |
| Enterprise Value | $2 | $2 | $1 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$1 | -$34 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.001 | 0 | -802 |
| % Growth | 35.7% | – | 100% | – |
| Operating Cash Flow | -$0 | -$0 | – | -$0 |
| Capital Expenditures | -$0 | -$0 | – | $0 |
| Free Cash Flow | -$0 | -$0 | – | -$0 |